Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Melanoma antitumor targeting medicine. The announcement comes amidst the recent completion of a series of preclinical experiments within the company's in-house research facilities demonstrating promising antitumor results on Melanoma cell lines.
Pharmaceutical, BioTech Product Launches and Technology Innovations
Crown Therapeutics, a division of Crown Laboratories, is proud to announce the launch of Sarna Eczema Relief Whipped Foam (Hydrocortisone 1%) – the first to market over-the-counter whipped foam eczema therapy product.
Lifeable, a dynamic manufacturer of vitamins and health products, is thrilled to announce the launch of a new line of supplements containing popular herbs and minerals such as Zinc and Ashwagandha.
KT Tape®, a leader in drug-free pain relief, today announced the latest innovation in its recovery product line up: KT Recovery+ Wave™ (KT Wave™).
The innovative design of the implant magnets from MED-EL is completely safe during an MRI examination. As of now, the global innovation leader in hearing solutions is emphasising this safety with an MRI guarantee that is as yet unmatched.